Novo Nordisk (NYSE:NVO) Q1 2026 Earnings call May 06, 2026 07:00 AM ET Company Participants Michael Novod Thank you very much, operator. Welcome to this Novo Nordisk earnings call for the first three months of 2026. My name is Michael Novod. I am the Head of Investor Relations at Novo Nordisk. With me today, I have CEO of Novo Nordisk, Mike Doustdar, EVP U.S. Operations, Jamey Millar, EVP International Operations, Emil Kongshøj Larsen, EVP Research and Development and Chief Scientific Officer, Martin Holst ...